MOTS-c Peptide: Mitochondrial Research Guide 2026

MOTS-c is among the most discussed peptides to emerge from mitochondrial biology research in the past decade. As a mitochondria-derived peptide (MDP) encoded within mitochondrial DNA itself, MOTS-c sits at the intersection of organelle biology, cell signaling, and one-carbon metabolism research.

For research use only. Not for human consumption.

What Is MOTS-c? Origins in Mitochondrial DNA

MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame within the 12S ribosomal RNA gene of mitochondrial DNA — not nuclear DNA. This makes MOTS-c part of a small but growing class of mitochondria-derived peptides that includes humanin and the SHLP family.

Its discovery by Changhan David Lee and colleagues, published in Cell Metabolism in 2015, fundamentally expanded our understanding of how mitochondria communicate with other cellular compartments. MOTS-c is secreted from mitochondria, enters the cytoplasm, and has been shown in research models to translocate to the nucleus in response to metabolic stress, where it modulates gene expression.

Signaling Research: AMPK

The most extensively studied aspect of MOTS-c biology is its relationship with AMPK (AMP-activated protein kinase), a cellular energy sensor often called the cell's "energy gauge." Published in-vitro and animal research has examined AMPK phosphorylation and downstream signaling after MOTS-c exposure (Lee et al., 2015).

• AMPK and ACC phosphorylation: Measured in C2C12 myotube cultures by Western blot as the core in-vitro readout.
• Mitochondrial respiration readouts: Some cell studies measured oxygen consumption and substrate utilization using extracellular flux analysis.
• Animal models: Rodent studies have examined MOTS-c distribution and signaling in liver and other tissues (Lee et al., 2015).
• Folate-methionine cycle interaction: Early research identified a functional interaction with the folate cycle in mitochondria.

Circulating Levels and Animal Studies

Several animal studies have measured circulating and tissue MOTS-c levels across different conditions, and others have administered MOTS-c to rodents to examine its whole-organism signaling (Reynolds et al., 2021). These studies are preclinical, their findings do not translate to humans, and they are cited here only for research context.

Gene Expression Research

Rodent and cell-culture studies have measured the expression of genes associated with mitochondrial biogenesis and oxidative phosphorylation after MOTS-c exposure. Readouts in this literature include AMPK activation, GLUT4 localization, and PGC-1α pathway engagement, typically measured by Western blot, immunofluorescence, and qPCR.

Research Supply and Quality

MOTS-c is a 16-amino-acid peptide that requires careful synthesis quality control. Researchers should review HPLC purity data and mass spectrometry identity data before use. Excalibur Peptides offers MOTS-c for in-vitro research use, and a Certificate of Analysis is published for this product.

Frequently Asked Questions

What is MOTS-c?

A mitochondria-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. Examined in published research on AMPK signaling, one-carbon metabolism, and cellular stress responses.

Why is MOTS-c described as a mitochondrial signaling peptide?

Because it is encoded in mitochondrial DNA and, in cell models, has been reported to move from the cytoplasm to the nucleus under metabolic stress, where it is associated with changes in nuclear gene expression. This makes it a tool for studying communication between mitochondria and the nucleus.

What animal research has examined MOTS-c?

Rodent studies have examined MOTS-c distribution, circulating levels, and whole-organism signaling (Lee et al., 2015; Reynolds et al., 2021). These are preclinical findings that do not translate to humans.

How is MOTS-c different from humanin?

Both are mitochondria-derived peptides but encoded by different mitochondrial DNA regions and act through different signaling pathways. MOTS-c is primarily studied in relation to AMPK and one-carbon metabolism; humanin has been studied more in apoptosis signaling research in neuronal cell models.

Is MOTS-c for human use?

No. MOTS-c is not approved for human use. It is sold for in-vitro research purposes only and is not intended for human consumption.

For research use only — not for human consumption.

Deeper Dive: The Molecular Mechanisms of MOTS-c Signaling

While the activation of AMP-activated protein kinase (AMPK) is the most prominent and frequently cited mechanism for MOTS-c, its signaling network is far more intricate. A comprehensive understanding for in-vitro experimental design requires an appreciation for its actions beyond this central pathway, including its ability to translocate to the nucleus and directly regulate gene expression, as well as its profound interaction with one-carbon metabolism.

Nuclear Translocation and Transcriptional Regulation

A defining feature that distinguishes MOTS-c from many other signaling peptides is its ability to move between cellular compartments. Originally discovered as a peptide secreted from mitochondria, subsequent research has demonstrated that under conditions of metabolic stress, MOTS-c can translocate to the cell nucleus. This organelle-to-nucleus communication is a critical aspect of its function.

In a landmark study by Lee et al. (2015), MOTS-c accumulation in the nucleus was associated with some of the gene-expression changes observed in cell models. Once in the nucleus, MOTS-c does not act as a classic transcription factor that directly binds DNA. Instead, it is described as a transcriptional co-regulator that interacts with other nuclear proteins. One pathway examined in this context is the transcription factor NRF2 (Nuclear factor erythroid 2-related factor 2), a central regulator of the cellular antioxidant response. Studies have measured NRF2 activity and the expression of genes containing the Antioxidant Response Element (ARE) in their promoters, such as heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1), after MOTS-c exposure. This line of work links mitochondrial status (as reported by MOTS-c) with the cell's oxidative stress response, a common topic in cell-stress and senescence research.

Further research has suggested that MOTS-c can also influence the activity of other transcription factors involved in metabolic homeostasis, though these interactions are still an active area of investigation. Designing experiments that involve separating nuclear and cytoplasmic fractions of treated cells can be a powerful way to dissect these location-specific effects of MOTS-c in vitro.

Intersection with the Folate-Methionine Cycle

One of the most specific mechanisms described for MOTS-c is its inhibition of the mitochondrial folate-methionine cycle. This pathway is essential for one-carbon metabolism, which provides methyl groups for a vast array of cellular processes, including DNA methylation (epigenetics), nucleotide synthesis (for DNA replication and maintenance), and the synthesis of S-adenosylmethionine (SAM), the universal methyl donor.

MOTS-c directly regulates this pathway by acting on the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR) and indirectly by modulating the de novo purine synthesis pathway. As reported by Zarse et al. (2021), MOTS-c acts as a competitive inhibitor of folate binding to enzymes in this cycle. This "metabolic brake" effectively shunts metabolites away from folate-mediated one-carbon metabolism and redirects them towards purine synthesis (the building blocks of DNA and RNA). This is a critical regulatory node. By inhibiting this pathway, MOTS-c forces a metabolic reprogramming that impacts cellular proliferation, epigenetic regulation, and redox balance.

This interaction is particularly relevant for researchers studying cellular proliferation. In rapidly dividing cell lines, the demand for nucleotides is high. MOTS-c's relationship with this pathway could be a key variable in experiments looking at cell growth rates, cell cycle progression, and responses to metabolic inhibitors. For example, co-treatment experiments combining MOTS-c with antifolate reference inhibitors (such as methotrexate) in various cell lines could reveal synergistic or antagonistic interactions and provide deeper insight into metabolic flexibility.

Emerging Non-AMPK Signaling Pathways

While AMPK activation is a consistent finding, it does not account for all of MOTS-c's observed effects in preclinical models. Research is beginning to uncover other signaling cascades that are modulated by MOTS-c.

One such pathway is the Mitogen-Activated Protein Kinase (MAPK) cascade. In certain cell types, particularly immune cells, studies have examined the phosphorylation status of key MAPK proteins like ERK1/2, JNK, and p38 after MOTS-c exposure. For instance, in macrophage cell lines (e.g., RAW 264.7) stimulated with lipopolysaccharide (LPS), studies have examined how MOTS-c relates to JNK and p38 MAPK phosphorylation and to cytokine production. This places MOTS-c within immunometabolism research, which studies links between cellular energy status and immune cell signaling.

Another line of investigation points to interactions with the TGF-β (Transforming Growth Factor-beta) signaling pathway. Lu et al. (2019) examined TGF-β1-induced differentiation of cardiac fibroblasts into myofibroblasts in the presence of MOTS-c, measuring the Smad2/3 signaling cascade, which is the canonical downstream pathway of TGF-β. This provides a mechanistic basis for including MOTS-c in in-vitro TGF-β signaling studies using cell types like hepatic stellate cells or cardiac fibroblasts.

Researchers designing experiments should consider that the dominant signaling pathway activated by MOTS-c may be cell-type specific and context-dependent, relying on the metabolic state of the cells and the presence of other stimuli.

Assuring Research Integrity: A Comprehensive Guide to Quality Control Testing

The reproducibility of any in-vitro experiment depends on the quality, purity, and identity of the reagents used. For synthetic peptides like MOTS-c, which serves as a precise signaling molecule in cellular assays, verifying its integrity is not an optional step but a fundamental requirement of good laboratory practice. Excalibur Peptides publishes a Certificate of Analysis (COA) for MOTS-c, and understanding the tests behind it allows researchers to interpret that document with confidence.

High-Performance Liquid Chromatography (HPLC) for Purity Assessment

HPLC is the standard technique for determining the purity of a synthetic peptide. The principle of this technique is to separate components in a mixture based on their chemical properties.

• Process: A small, precisely measured amount of the synthesized MOTS-c is dissolved in a solvent and loaded onto the HPLC system by the autosampler. It is then pumped under high pressure through a column packed with a solid material (the stationary phase). A liquid solvent mixture (the mobile phase) is continuously run through the column. Components of the sample interact differently with the stationary phase; molecules with higher affinity for the stationary phase move more slowly, while those with lower affinity move more quickly.
• Detection: As the separated components exit the column, they pass through a UV detector. Peptide bonds absorb UV light at a specific wavelength (typically 214-220 nm). The detector measures this absorbance, generating a signal that is proportional to the amount of peptide present.
• The Chromatogram: The output is an HPLC chromatogram, a graph of UV absorbance versus time. An ideally pure sample would yield a single, sharp peak. The time at which this peak appears (the retention time) is characteristic of MOTS-c under specific HPLC conditions. Any other peaks represent impurities, which could be deletion sequences (peptides missing one or more amino acids), incompletely deprotected sequences, or residual reagents from synthesis. Purity is calculated by measuring the area of the main MOTS-c peak as a proportion of the total area of all peaks in the chromatogram. The chromatogram and its integration conditions should be read together with the reported value.

Mass Spectrometry (MS) for Identity Verification

While HPLC confirms purity, it does not confirm identity. It is possible for an impurity to have a similar retention time to the target peptide. Mass Spectrometry (MS) is therefore used to confirm that the main peak identified by HPLC is indeed MOTS-c by verifying its molecular weight.

• Process: Following synthesis and purification, a sample is introduced into the mass spectrometer, where it is ionized—given an electrical charge. Common ionization techniques for peptides include Electrospray Ionization (ESI) or Matrix-Assisted Laser Desorption/Ionization (MALDI). The charged peptide ions are then accelerated into a magnetic or electric field within the mass analyzer.
• Separation and Detection: The analyzer separates the ions based on their mass-to-charge ratio (m/z). Lighter ions are deflected more by the field, while heavier ions are deflected less. A detector at the end of the flight path registers the intensity of ions at each m/z value.
• The Mass Spectrum: The output is a mass spectrum, a graph of ion intensity versus m/z. For MOTS-c (sequence: MRWQEMGYIFYPRKLR), the theoretical monoisotopic molecular weight is calculated based on the sum of the atomic masses of its constituent amino acids. The mass spectrum for authentic MOTS-c must show a prominent peak that corresponds to this calculated theoretical mass. This provides unambiguous confirmation of the peptide's identity.

LAL Endotoxin Testing for In-Vitro Work

Endotoxins, also known as lipopolysaccharides (LPS), are components of the outer membrane of Gram-negative bacteria. They are potent activators of innate immune signaling and can dramatically alter cellular behavior, even at picogram-per-milliliter concentrations. Their presence in a peptide preparation can confound experimental data, particularly in immunology, cell signaling, or metabolism studies.

• The LAL Assay: The industry standard for endotoxin detection is the Limulus Amebocyte Lysate (LAL) test. This assay utilizes a clotting factor cascade found in the blood cells (amebocytes) of the horseshoe crab, Limulus polyphemus. This cascade is exquisitely sensitive to the presence of endotoxins.
• Methodology: In the chromogenic LAL test, the peptide sample is incubated with the LAL reagent. If endotoxin is present, it will trigger the enzymatic cascade. The final enzyme in the cascade cleaves a chromogenic substrate, producing a colored product (typically yellow). The intensity of this color, measured with a spectrophotometer, is directly proportional to the amount of endotoxin in the sample.
• Specification: Values are reported in Endotoxin Units per milligram (EU/mg). For research peptides intended for use in cell culture, a low endotoxin level is important. Researchers should set an endotoxin limit suited to their cell system in advance and check whether the COA reports an endotoxin value; if it does not, an in-house LAL test before use is advisable.

Additional QC Metrics: Peptide Content, Water Content, and Residual Solvents

A comprehensive COA may also include other important parameters:

• Peptide Content (Net Peptide): Lyophilized peptide powder is not pure peptide. It also contains counter-ions (like trifluoroacetate, or TFA, from the HPLC purification process) and bound water. Peptide content analysis (often determined by quantitative amino acid analysis or nitrogen analysis) measures the actual proportion of the powder by weight that is the peptide. This value is crucial for accurately calculating the concentration when preparing stock solutions for assays.
• Water Content (Karl Fischer Titration): This test specifically quantifies the amount of water present in the lyophilized powder. This is important for stability and for accurately calculating peptide concentration.
• Residual Solvents (Gas Chromatography): This analysis checks for the presence of any residual organic solvents (e.g., acetonitrile, dichloromethane) used during the peptide synthesis and purification process. Levels should fall within the limits specified for chemical reagents.

Contextualizing MOTS-c: A Review of Foundational Preclinical Research

To effectively design in-vitro experiments, it is vital to understand the foundational preclinical literature that established the biological relevance of MOTS-c. The following summaries of key animal-model studies provide context for its major research applications.

The Discovery and Initial Characterization in Rodent Models (Lee et al., 2015)

The seminal paper published in Cell Metabolism by Changhan David Lee and his colleagues from the Pinchas Cohen lab at UCLA was the first to identify and characterize MOTS-c. This study laid the groundwork for all subsequent research.

• Methodology: The researchers used bioinformatic tools to scan the mitochondrial genome for short open reading frames (sORFs) that could potentially encode peptides. They identified the sORF within the 12S rRNA gene and characterized the resulting 16-amino-acid peptide, which they named MOTS-c. They used cell culture systems (C2C12 myotubes, derived from a mouse myoblast line) and mouse models (primarily C57BL/6J) maintained on defined diets, with all animal work conducted under institutional animal-care oversight.
• Main Areas Examined:
  1. AMPK Signaling: Phosphorylation of AMPK and its downstream target ACC (Acetyl-CoA Carboxylase) was measured in C2C12 cultures by Western blot.
  2. Tissue Distribution: MOTS-c was detected in several mouse tissues and in circulation, establishing it as an endogenous peptide that can be measured outside the mitochondrion.
  3. Pathway Profiling: Transcriptomic and metabolomic profiling of treated cells identified changes in pathways connected to one-carbon metabolism and purine synthesis.
  4. Nuclear Translocation: The study provided evidence that MOTS-c translocates to the nucleus in response to metabolic stress and can regulate gene expression.
  5. Folate Cycle Interaction: The study also first hinted at the unique mechanism involving the folate-methionine cycle, which was explored in more detail in later work.

This paper established MOTS-c as a mitochondrial-encoded signaling peptide in rodent and cell models, a finding that launched the field.

Later Rodent Studies (Reynolds et al., 2021)

A later study by Reynolds et al. in Nature Communications extended MOTS-c research to rodents of different ages, examining circulating levels, tissue signaling, and a panel of functional endpoints.

• Methodology: The research team used mice of different ages and measured circulating MOTS-c, tissue gene expression, and several functional endpoints, with all animal work conducted under institutional animal-care oversight. Cell-culture experiments were run alongside the animal work to examine the pathways involved.
• Relevance for In-Vitro Work:
  1. Pathway Focus: The study connected MOTS-c to the folate-methionine-purine synthesis pathway and to NAD+ metabolism, both of which can be studied directly in cultured cells.
  2. Cell-Stress Readouts: Redox balance and nucleotide pool measurements used in the study (e.g., glutathione ratios and purine metabolite profiling by LC-MS) translate readily to cell-culture designs.
  3. Preclinical Scope: All interventional findings in this literature come from animal and cell models. They do not establish any effect in humans, and MOTS-c is not approved for human use.

This work broadened the range of pathways that laboratories examine alongside MOTS-c, particularly one-carbon metabolism and NAD+ metabolism.

MOTS-c in Osteoblast Differentiation Models (Miller et al., 2020)

Expanding beyond myotube and metabolic signaling models, research has also examined MOTS-c in other cell types. A study by Miller et al. published in The FASEB Journal examined bone-derived cells in culture.

• Methodology: The study used in-vitro cultures of osteoblastic cells (MC3T3-E1) and primary bone marrow stromal cells. These cells were exposed to MOTS-c, and their differentiation into mature osteoblasts was assessed. Markers of osteogenesis, such as alkaline phosphatase (ALP) activity, collagen production, and mineralization (calcium deposition), were measured. The team also used an ex vivo model of mouse calvaria (skull bone) organ culture.
• Main Readouts:
  1. Differentiation Markers: Alkaline phosphatase activity and the expression of osteogenic transcription factors such as Runx2 were measured in treated and control cultures.
  2. Mineralization: Calcium deposition onto the extracellular matrix was quantified by Alizarin Red staining as the final differentiation readout.
  3. TGF-β/SMAD Pathway: In these bone-derived cells, the signaling examined was attributed to the TGF-β/SMAD pathway rather than AMPK, with TGF-β receptor expression and SMAD1/5/8 phosphorylation measured.

This study was crucial as it demonstrated that MOTS-c's mechanism of action is tissue-specific. This highlights the importance for researchers to design experiments that account for the unique signaling environment of their chosen cell type or in-vitro model.

Laboratory Handling of Lyophilized MOTS-c

MOTS-c is supplied as a white, lyophilized (freeze-dried) powder, the form in which a peptide changes most slowly. On arrival, transfer the sealed vial promptly to storage at the temperature listed on the product page (−20 °C), protected from light and moisture, and avoid frequent temperature fluctuations. Before opening, let a cold vial reach room temperature so that moisture does not condense on the powder.

Solution preparation: Excalibur Peptides does not publish preparation instructions. Laboratories choose solvents, concentrations and handling according to their own validated standard operating procedures, the published literature for MOTS-c and the net content reported on the Certificate of Analysis, and record the solvent, its lot and the date in their methods.

Whatever procedure a laboratory follows, cell-culture experiments include a vehicle control that receives the same solvent without the peptide, so that an observed response can be attributed to MOTS-c rather than to the solvent.

Comparative Analysis: MOTS-c and Other Mitochondria-Derived Peptides (MDPs)

MOTS-c is a prominent member of a growing class of peptides known as Mitochondria-Derived Peptides (MDPs). These are all encoded by short open reading frames (sORFs) within the mitochondrial DNA, a genome once thought to code for only 13 proteins, 2 rRNAs, and 22 tRNAs. The discovery of MDPs has revealed a new layer of mitochondrial signaling. Understanding the similarities and differences between these peptides is crucial for selecting the appropriate research tools and for interpreting experimental outcomes.

Distinctions in Function and Mechanism

While all MDPs originate from the mitochondrion and act as signaling molecules, their biological roles and mechanisms diverge significantly.

• MOTS-c vs. Humanin: This is the most studied comparison. MOTS-c is primarily studied in relation to AMPK signaling and one-carbon metabolism, including energy sensing via AMPK and interaction with intracellular pathways like the folate cycle. Humanin, in contrast, is primarily characterized in apoptosis signaling research. In numerous in-vitro and animal studies, it has been examined in relation to programmed cell death induced by a wide range of stressors. Its receptor and downstream signaling cascade (STAT3) are distinct from MOTS-c's primary targets. Both peptides have been examined in cell-stress research, but through different pathways and with different experimental readouts.

• The SHLP Family: The Small Humanin-Like Peptides (SHLPs) are a family of six peptides also encoded by the 16S rRNA gene, like Humanin. Their discovery highlighted the unexpected coding capacity of this region. Research on the individual SHLPs is less mature than for MOTS-c or Humanin, but they appear to have diverse and sometimes opposing functions. For example, some SHLPs have been associated with increased proliferation in certain transformed cell lines, while others have been associated with decreased proliferation. SHLP2 has been examined individually in mitochondrial respiration and cell viability studies. The SHLPs represent a frontier in MDP research, with their specific receptors and pathways still being actively investigated.

For researchers, this diversity means MOTS-c cannot be used as a proxy for all MDPs. An experiment designed to study metabolic flux using MOTS-c will probe different pathways than one designed to study neuronal apoptosis using Humanin. The choice of peptide must be precisely matched to the scientific question and the biological system under investigation.

Expanded Research FAQ

What is the native structure of MOTS-c and the role of its N-terminal methionine? Native MOTS-c synthesized within the mitochondrion begins with an N-formylmethionine (fMet), a characteristic of prokaryotic and organellar protein synthesis. However, this formyl group is often cleaved post-translationally. Commercially available synthetic MOTS-c, including the material used in most published research, consists of the 16-amino acid sequence starting with a standard methionine (Met-Arg-Trp-Gln...). This non-formylated version is the form used in most published cell and animal studies. The formylated version may have different stability or activity profiles, but the non-formylated version is the established standard for research.

How does MOTS-c signaling differ between myotube and hepatocyte cell models? The published readouts differ between the two cell types. In C2C12 myotube studies, the literature focuses on AMPK and ACC phosphorylation and on the subcellular localization of the transporter GLUT4. In hepatocyte lines such as HepG2, AMPK is also measured, and studies have additionally examined the expression of hepatic enzyme genes such as G6PC and PCK1. MOTS-c's interaction with the folate cycle may also be more prominent in hepatocyte models because of the liver's central role in one-carbon metabolism.

Are there known antagonists for blocking MOTS-c action in co-culture experiments? Currently, there is no commercially available, specific small-molecule antagonist that selectively blocks MOTS-c action. In research settings, blocking its effects has been achieved using molecular biology techniques. For example, to block the effects of AMPK activation, researchers can use the well-known AMPK inhibitor, Compound C, in co-treatment experiments. To investigate the role of nuclear translocation, experiments could be designed using inhibitors of nuclear import or by using cell lines where key downstream targets (like NRF2) have been knocked down using siRNA or CRISPR.

What is the relevance of MOTS-c binding to the 5' noncoding region of AICAR transformylase (ATIC)? This finding, related to the folate-methionine cycle, is one of MOTS-c's most specific interactions. ATIC is a bifunctional enzyme involved in de novo purine synthesis. MOTS-c has been described as inhibiting this enzyme, which puts a brake on the purine synthesis pathway downstream of the folate cycle. This shunts one-carbon units away from this pathway and changes the metabolic priorities of the cell. It is proposed to underlie several of the changes in one-carbon metabolism and AMPK signaling reported in cell models, since accumulation of the ATIC substrate AICAR is itself a known AMPK activator.

In in-vitro assays, what concentration ranges appear in published MOTS-c work? The appropriate concentration for MOTS-c in an assay depends on the cell type, assay duration, and the specific endpoint being measured. Published cell culture work commonly uses concentrations in the low micromolar range. For example, studies on C2C12 myotubes have used concentrations around 10 µM when measuring AMPK phosphorylation within a few hours, and osteoblast differentiation studies have used similar concentrations over several days. Researchers should perform a concentration-response experiment (e.g., 0.1 µM, 1 µM, 10 µM, 25 µM) to determine a suitable concentration for their own experimental system.

Why is MOTS-c considered a "homeostatic" regulator? MOTS-c is described as a homeostatic regulator because its expression and subcellular location are linked to the cell's metabolic state. Under unstressed culture conditions, its levels are basal. Under metabolic stress in culture, such as nutrient restriction or oxidative stress, studies report changes in its expression and its movement to the nucleus. It is therefore described as a feedback signal from the mitochondria to the rest of the cell rather than as a one-directional switch.

Can MOTS-c be used in organoid or 3D culture models? Yes, MOTS-c is a reasonable candidate for investigation in more complex in-vitro systems like organoids or 3D spheroids. These models better recapitulate the tissue microenvironment. For example, 3D myotube cultures exposed to MOTS-c could provide data on mitochondrial biogenesis markers and AMPK signaling in a more tissue-like context than 2D cultures. Similarly, TGF-β signaling could be studied in 3D liver or cardiac fibroblast cultures. Researchers should validate peptide penetration into the organoid and may need to use slightly higher concentrations or longer incubation times compared to monolayer cultures.

What should researchers check on a MOTS-c Certificate of Analysis? Start with identity: the sequence (MRWQEMGYIFYPRKLR) and an intact mass by mass spectrometry that matches the theoretical value of roughly 2174.6 Da. MOTS-c contains two methionine residues, so a secondary peak at +16 Da in the mass spectrum can indicate methionine oxidation, which is worth noting before use. Next, review the HPLC chromatogram and its integration, the counter-ion (usually acetate or trifluoroacetate), and, where reported, the peptide content and water content, which are needed for accurate molar calculations. Store the lyophilized material at -20°C and protect prepared solutions from repeated freezing and thawing to limit oxidation and hydrolysis.

Glossary of Technical Terminology

• AMP-activated protein kinase (AMPK): A key cellular energy sensor. It is activated when the ratio of AMP to ATP increases (a sign of low energy) and initiates signaling cascades to increase energy production and reduce energy consumption.
• Aliquot: A portion of a whole; in the lab, it refers to dividing a larger volume of a solution (like a peptide stock) into smaller, single-use volumes to prevent contamination and degradation from repeated handling or repeated freezing and thawing.
• Certificate of Analysis (COA): A document issued by a supplier that confirms a product meets its predetermined specifications. For peptides, it includes data on purity (from HPLC), identity (from MS), and other quality control parameters.
• Counter-ion: An ion, such as acetate or trifluoroacetate, that remains associated with a peptide after purification and lyophilization and contributes to the gross weight of the powder.
• Endotoxin (LPS): Lipopolysaccharide, a component of the outer membrane of Gram-negative bacteria. It is a potent activator of innate immune signaling that can confound in-vitro experiments if present as a contaminant.
• Folate-Methionine Cycle: A critical metabolic pathway involved in one-carbon metabolism, responsible for producing methyl groups for DNA methylation, as well as building blocks for DNA, RNA, and proteins.
• High-Performance Liquid Chromatography (HPLC): An analytical chemistry technique used to separate, identify, and quantify each component in a mixture. It is the standard method for assessing peptide purity.
• Limulus Amebocyte Lysate (LAL) Assay: A highly sensitive test used to detect the presence of bacterial endotoxins, based on the clotting reaction of blood from the horseshoe crab.
• Lyophilization: A freeze-drying process that removes water from a product after it is frozen and placed under a vacuum. This process stabilizes peptides for long-term storage and shipping.
• Mass Spectrometry (MS): An analytical technique used to measure the mass-to-charge ratio of ions. For peptides, it is used to confirm the molecular weight, thereby verifying the peptide's identity.
• Mitochondria-Derived Peptide (MDP): A class of bioactive peptides that are encoded by short open reading frames within the mitochondrial DNA, rather than the nuclear DNA.
• Nuclear Factor Erythroid 2-Related Factor 2 (NRF2): A transcription factor that regulates the expression of a wide array of antioxidant and detoxification genes, forming a primary cellular defense against oxidative stress.
• Open Reading Frame (ORF): A continuous stretch of codons in DNA or RNA that has the potential to be translated into a protein or peptide.
• PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha): A master transcriptional coactivator that regulates mitochondrial biogenesis, cellular respiration, and metabolic programming in response to cellular energy demands.
• Stock Solution: A concentrated solution prepared by dissolving a lyophilized (freeze-dried) powder in a suitable solvent, from which working dilutions are made for laboratory assays.

References

• D'Souza, R. F., et al. (2019). Nature Communications, 10(1).
• Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., ... & Cohen, P. (2015). Cell Metabolism, 21(3), 443-454.
• Lu, H., Wei, M., Zhai, C., et al. (2019). American Journal of Translational Research, 11(12), 7349–7361.
• Miller, B., Kim, S. J., Kumagai, H., Yen, K., & Cohen, P. (2020). The FASEB Journal, 34(7), 9573-9584.
• Reynolds, J. C., Rocchi, A., Croteau, D. L., et al. (2021). Nature Communications, 12(1), 470.
• Zarse, K., Miller, B., & Cohen, P. (2021). MOTS-c and the Mitochondrial Regulation of the Folate-Methionine Cycle. Antioxidants & Redox Signaling, 34(8), 619–630.

This product is intended for laboratory research use only. It is not sold as a drug, supplement, or food item, is not approved by the FDA for human or veterinary use, and is not intended for human consumption or for use in any diagnostic procedure. The information presented here is for educational purposes and is based on published research in in-vitro and animal models. Any discussion of mechanisms or findings from this research is not a claim about the product's use in humans. All handling and use of this product must be performed by qualified professionals in a controlled laboratory setting. Please refer to your institutional guidelines and safety procedures for proper handling. For any questions regarding the supply of this material, please contact our support team at info@excaliburpeptides.com.